Last 12 months
Inside the activity.
0 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2019 Filed May 15, 2019 23:26 UTC |
Bauer Joanne BDirector
|
SaleCommon Stock | 3,798 | $81.72 | $310,366.86 |
DisclosureSEC source: 0001179110-19-006119 · edgar.xml · nonDerivative · entry 3 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,835 F2 · price: The price reported in Column 4 is the average price of $81.7185. The sold price range between $81.7150 to $81.78. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:26 UTC |
Bauer Joanne BDirector
|
GrantCommon Stock | 2,319 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006119 · edgar.xml · nonDerivative · entry 2 Bauer Joanne B · CIK 0001359343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,633 F1 · shares: Grant of restricted shares in consideration of services as a member of the Board of Directors. Shares vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:26 UTC |
PARRISH MARK WDirector
|
GrantCommon Stock | 2,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006118 · edgar.xml · nonDerivative · entry 2 PARRISH MARK W · CIK 0001236452 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,594 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:24 UTC |
Judson James TDirector
|
GrantCommon Stock | 2,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006116 · edgar.xml · nonDerivative · entry 2 Judson James T · CIK 0001326789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,970 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:24 UTC |
WHITE SARA JDirector
|
GrantCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006115 · edgar.xml · nonDerivative · entry 2 WHITE SARA J · CIK 0001227559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,755 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:19 UTC |
Seim Robin GeneDirector
|
GrantStock Options NQ (Right to Buy) · Derivative | 6,381 | $0.00 Strike: $81.92 | $0.00 |
DisclosureSEC source: 0001179110-19-006114 · edgar.xml · derivative · entry 3 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,381 Underlying: Common Stock · 6,381 shares Expires 2029-05-13 F2 · shares: Initial Stock Option grant will vest as to 1/3 of the shares on each anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 15, 2019 23:19 UTC |
Seim Robin GeneDirector
|
GrantCommon Stock | 1,953 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006114 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,528 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed May 16, 2019 16:17 UTC |
Scott Bruce EDirector
|
GrantStock Options NQ (Right to Buy) · Derivative | 6,381 | $0.00 Strike: $81.92 | $0.00 |
DisclosureSEC source: 0001179110-19-006140 · edgar.xml · derivative · entry 2 Scott Bruce E · CIK 0001776980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,381 Underlying: Common Stock · 6,381 shares Expires 2029-05-13 F1 · shares: Initial Stock Option grant will vest as to 1/3 of the shares on each anniversary of the date of grant. Read SEC document |
| May 14, 2019 Filed May 16, 2019 16:17 UTC |
Scott Bruce EDirector
|
GrantCommon Stock | 2,044 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006140 · edgar.xml · nonDerivative · entry 1 Scott Bruce E · CIK 0001776980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,044 F2 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 14, 2019 Filed Jul 8, 2019 19:52 UTC Amendment |
WHITE SARA JDirector
|
GrantCommon Stock | 2,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-008527 · edgar.xml · nonDerivative · entry 2 WHITE SARA J · CIK 0001227559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,225 F1 · shares: Grant of restricted shares in consideration of services as a Board Member. Shares shall vest in full on the date of the Company's 2020 Annual Meeting of Stockholders. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:18 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 8,500 | $0.00 Strike: $43.30 | $0.00 |
DisclosureSEC source: 0001179110-19-005922 · edgar.xml · derivative · entry 5 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,500 shares Expires 2028-04-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:18 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 4,900 | $82.10 | $402,266.48 |
DisclosureSEC source: 0001179110-19-005922 · edgar.xml · nonDerivative · entry 4 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,929 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F3 · price: The price reported in Column 4 is the average price of $82.0952. The sold price range between $81.77 to $82.7699. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:18 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
SaleCommon Stock | 3,600 | $81.11 | $292,002.84 |
DisclosureSEC source: 0001179110-19-005922 · edgar.xml · nonDerivative · entry 3 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,829 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F2 · price: The price reported in Column 4 is the average price of $81.1119. The sold price range between $80.67 to $81.6699. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2019 Filed May 13, 2019 18:18 UTC |
Seidelmann Scott PeterEVP, Chief Commercial Officer
|
Exercise / conversionCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005922 · edgar.xml · nonDerivative · entry 2 Seidelmann Scott Peter · CIK 0001736895 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 20 | $82.37 | $1,647.31 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 7 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,715 F4 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $82.80 to $83.21. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 994 | $82.37 | $81,871.21 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 6 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,735 F3 · shares: The price reported in Column 4 is the average price of $82.3654. The sold price range between $81.00 to $81.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $82.10 to $82.79. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 100 | $82.37 | $8,236.54 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 5 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,729 F3 · price: The price reported in Column 4 is the average price of $82.3654. The sold price range between $81.00 to $81.98. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 717 | $0.00 Strike: $36.70 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 11 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 717 shares Expires 2027-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 8,880 | $0.00 Strike: $44.25 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 10 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,880 shares Expires 2028-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 726 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 9 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 726 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,563 | $0.00 Strike: $32.78 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · derivative · entry 8 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,563 shares Expires 2025-08-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 9,750 | $81.34 | $793,083.53 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 4 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,829 F2 · price: The price reported in Column 4 is the average price of $81.3419. The sold price range between $81.20 to $81.6675. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
SaleCommon Stock | 2,136 | $82.51 | $176,246.91 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 3 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,579 F1 · price: The price reported in Column 4 is the average price of $82.5126. The sold price range between $82.25 to $82.75. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 07, 2019 Filed May 8, 2019 23:56 UTC |
Kuipers Peter J.Executive V P& CFO
|
Exercise / conversionCommon Stock | 11,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005741 · edgar.xml · nonDerivative · entry 2 Kuipers Peter J. · CIK 0001651691 · Executive V P& CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · derivative · entry 16 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,000 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 13,282 | $0.00 Strike: $25.08 | $0.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · derivative · entry 15 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,282 shares Expires 2024-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
OtherCommon Stock | 36,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 14 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 311,909 F12 · shares: Transfer from shares held directly by Mr. Lipps to shares held in trust with Mr. Lipps' wife. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
OtherCommon Stock | 36,296 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 13 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,506 F12 · shares: Transfer from shares held directly by Mr. Lipps to shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 5,000 | $79.59 | $397,970.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 12 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · In Trust with Wife Disclosed balance after: 275,613 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F11 · price: The price reported in Column 4 is the average price of $79.5940. The sold price range between $76.89 to 81.39. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F1 · ownership.nature: Shares held in trust with Mr. Lipps' wife. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 11,000 | $78.28 | $861,114.10 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 11 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,802 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F10 · price: The price reported in Column 4 is the average price of $78.2831. The sold price range between $78.00 to $79.04. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,766 | $79.62 | $140,601.86 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 10 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,802 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F9 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $81.20 to $81.45. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 3,407 | $79.62 | $271,251.71 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 9 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,568 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F8 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $80.18 to $81.18. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 4,100 | $79.62 | $326,425.60 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 8 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,975 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F7 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $79.00 to $79.99. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 2,600 | $79.62 | $207,001.60 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 7 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,075 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F6 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $77.96 to $78.9150. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
SaleCommon Stock | 1,409 | $79.62 | $112,178.94 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 6 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,675 F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. F5 · price: The price reported in Column 4 is the average price of $79.6160. The sold price range between $76.94 to $77.93. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 29, 2019 Filed May 2, 2019 00:11 UTC |
LIPPS RANDALL ADirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 24,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005372 · edgar.xml · nonDerivative · entry 5 LIPPS RANDALL A · CIK 0001227556 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 24, 2019 Filed May 7, 2019 20:12 UTC |
Seim Robin GeneDirector
|
GrantCommon Stock | 246 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-005642 · edgar.xml · nonDerivative · entry 2 Seim Robin Gene · CIK 0001351911 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,575 F1 · shares: Grant of restricted shares in consideration of services as a member of the Board of Directors. Shares vest in full on the date of the Company's 2019 Annual Meeting of Stockholders. F2 · shares: This Form 4 is being filed late due to an inadvertent administrative error. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 6,041 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · derivative · entry 7 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,041 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 209 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · derivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 209 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 1,960 | $81.14 | $159,037.93 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · nonDerivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,544 F4 · price: The price reported in Column 4 is the average price of $81.1418. The sold price range between $80.37 to $81.90. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 209 | $82.00 | $17,138.00 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,504 F3 · price: The price reported in Column 4 is the exact price of $82.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 6,041 | $81.14 | $490,155.87 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,713 F2 · price: The price reported in Column 4 is the average price of $81.1382. The sold price range between $80.30 to $82.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed Apr 16, 2019 15:12 UTC |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-004961 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 6,041 | $0.00 Strike: $27.70 | $0.00 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · derivative · entry 7 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,041 shares Expires 2026-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 209 | $0.00 Strike: $34.02 | $0.00 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · derivative · entry 6 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 209 shares Expires 2025-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 1,960 | $81.14 | $159,037.93 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · nonDerivative · entry 5 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,258 F4 · price: The price reported in Column 4 is the average price of $81.1418. The sold price range between $80.37 to $81.90. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 209 | $82.00 | $17,138.00 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · nonDerivative · entry 4 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,218 F3 · price: The price reported in Column 4 is the exact price of $82.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
SaleCommon Stock | 6,041 | $81.14 | $490,155.87 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · nonDerivative · entry 3 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,427 F2 · price: The price reported in Column 4 is the average price of $81.1382. The sold price range between $80.30 to $82.00. The reporting person undertakes to provide to Omnicell, Inc., any security holder of Omnicell, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2019 Filed May 22, 2019 22:20 UTC Amendment |
JOHNSTON DAN SEVP & Chief Legal & Admin
|
Exercise / conversionCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-006545 · edgar.xml · nonDerivative · entry 2 JOHNSTON DAN S · CIK 0001271802 · EVP & Chief Legal & Admin 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
| March 21, 2019 Filed Mar 21, 2019 22:08 UTC |
Ngo Nhat HEVP, Marketing, S & B D
|
Exercise / conversionStock Options NQ (Right to Buy) · Derivative | 1,823 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001179110-19-004151 · edgar.xml · derivative · entry 4 Ngo Nhat H · CIK 0001305020 · EVP, Marketing, S & B D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,823 shares Expires 2022-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.